Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1200 of 5804
-
New drug avelumab aims to keep upper tract cancer at bay after chemo
Disease control Recruiting nowA Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug aims to help patients shed pounds after failed weight-loss surgery
Disease control Recruiting nowThis clinical trial aims to evaluate the weight-loss efficacy and safety of efsubaglutide alfa in patients who remain obese 6 months after metabolic surgery.
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New device aims to grow gut length for short bowel patients
Disease control Recruiting nowA Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients with Short Bowel Syndrome
Phase: NA • Sponsor: Eclipse Regenesis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can zapping the brain slow language decline? new trial investigates
Symptom relief Recruiting nowThe goal of this clinical trial is to investigate the effect of non-invasive brain stimulation techniques in the progression of primary progressive aphasia for 6 months. We will compare three modalities of brain stimulation (TMS, tDCS, TMS+tDCS) against sham stimulation. All pati…
Phase: NA • Sponsor: Hospital San Carlos, Madrid • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New combo attack on myeloma: antibody first, then CAR-T
Disease control Not yet recruitingThis study is a prospective, single-arm, multicenter trial designed to evaluate the hematologic response rate and safety of GPRC5D/CD3 bispecific antibody bridging therapy prior to CAR-T cell infusion in patients with relapsed/refractory multiple myeloma (RRMM).
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI-Powered test aims to predict best cancer treatment for each patient
Diagnosis Not yet recruitingThe study aims to evaluate the clinical utility of the xDRIVE functional precision medicine + artificial intelligence (AI) platform in predicting treatment response for metastatic colorectal cancer (mCRC). The primary objective is to assess xDRIVE's accuracy in forecasting clinic…
Sponsor: First Ascent Biomedical Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 17:44 UTC
-
Double antibiotic attack on staph blood infections shows promise
Disease control ENROLLING_BY_INVITATIONThe goal of this open-label, pragmatic, randomized controlled clinical trial is to learn if patients with Staphylococcus aureus bacteremia (SAB) given the intervention of early dual intravenous (IV) antibiotic therapy will decrease duration of bacteremia (\< 6 days) and improve o…
Phase: PHASE4 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 26, 2026 18:13 UTC
-
Magnetic pulses could ease knee arthritis without drugs or surgery
Symptom relief Recruiting nowThis randomized, double-blind clinical trial aims to evaluate the effect of high-intensity pulsed electromagnetic field therapy (HI-PEMF) applied either exclusively on the knee joint or bimodally on the knee and quadriceps, in older adults with knee osteoarthritis. Both groups wi…
Phase: NA • Sponsor: Hospital Civil de Guadalajara • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Could a flower extract help stroke patients recover?
Disease control Recruiting nowAlthough mechanical thrombectomy or thrombolytic therapy for large vessels can achieve a revascularization rate (TICI ≥2b) of over 90%, 30-50% of patients still exhibit poor functional outcomes. This phenomenon of "ineffective reperfusion" suggests that microcirculatory dysfuncti…
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Yueyang Integrated Medicine Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC
-
Lifestyle makeover for IBD: diet and stress coaching tested alongside meds
Disease control Recruiting nowInflammatory Bowel Disease (IBD), which includes Crohn's Disease (CD) and Ulcerative Colitis (UC), is a chronic, immune-mediated disease characterized by recurrent episodes of relapse. The goal of this single site, pragmatic, randomized trial is to answer if combining lifestyle m…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
AI health coach aims to tame diabetes in indonesia
Disease control Not yet recruitingThis study aims to evaluate the effectiveness of a virtual health coaching program based on artificial intelligence (AI) in improving blood sugar control among people with type 2 diabetes in primary health care settings in Jeneponto and Bantaeng, Indonesia. The intervention will …
Phase: NA • Sponsor: Hasanuddin University • Aim: Disease control
Last updated Jun 26, 2026 16:24 UTC
-
Radiation after surgery may keep rare adrenal cancer at bay
Disease control Not yet recruitingThis study is a prospective, randomized, controlled, multicenter clinical trial designed to evaluate whether adjuvant radiotherapy can improve the 3-year recurrence-free survival (RFS) in high-risk localized adrenocortical carcinoma (ACC) patients after radical resection. Accordi…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
Could a Half-Dose of a common drug prevent a painful complication just as well?
Prevention Recruiting nowEndoscopic Retrograde Cholangiopancreatography (ERCP) is a widely used procedure for diagnosing and treating pancreatic and biliary diseases. Despite its benefits, ERCP carries a risk of post-procedure pancreatitis (PEP), which occurs in approximately 12.2% of cases and can signi…
Phase: PHASE4 • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Stem cells injected into ALS patients in first human trial
Disease control Recruiting nowA Phase I Study to Assess the Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects with Amyotrophic Lateral Sclerosis
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Real-World study checks if immunotherapy works for advanced lung cancer patients
Disease control Recruiting nowThis prospective, multicenter, real-world observational study aims to evaluate the clinical outcomes of first-line atezolizumab monotherapy in patients with stage IV non-small cell lung cancer (NSCLC) with PD-L1 tumor cell expression ≥50% and no targetable mutations. The study ai…
Sponsor: Antalya Training and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Sleep apnea study tests CPAP plus sleep meds for better blood pressure control
Disease control Recruiting nowResearch Title "Quadruple-Blind Randomized Controlled Trial of the Effect of CPAP on Blood Pressure in Patients with Sleep Apnea" Why are we conducting this study? * Sleep apnea (OSA) is very common, affecting approximately one in every eight adults. It makes it more difficult t…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New gene therapy CREPT-618 enters human trials for liver cancer
Disease control Recruiting nowThis is a single-center, open-label, dose-escalation Phase I clinical study designed to evaluate the safety (incidence of adverse events), maximum tolerated dose (MTD), optimal biological dose (OBD), and recommended Phase II dose (RP2D) of CREPT-618 in adult patients aged 18-75 w…
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Ear-Zapping device could tame brain swelling after stroke
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with acute intracerebral hemorrhage (ICH). The taVNS intervention will be delivered using the BS-TVNS800-1 transcutaneous electrical stimulation therapy dev…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New blood clotting drug could cut transfusions in heart surgery
Disease control Recruiting nowThis is a phase 3, multicenter, randomized, open-label, parallel-group, controlled study to assess the efficacy and safety of BE1116 compared with fresh frozen plasma (FFP) in adult participants undergoing complex cardiovascular surgery with CPB. The primary purpose of the study …
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Custom mRNA vaccine takes on Hard-to-Treat cancers
Disease control Not yet recruitingThis is a Phase 1 clinical study investigating RH125 as monotherapy or in combination therapy in patients with locally advanced or metastatic solid tumors who failed standard treatment, or were intolerant to standard treatment, or declined standard treatment. The aim of the study…
Phase: EARLY_PHASE1 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC